Related Experiment Videos

Effects of (D-Ala2)methionine enkephalinamide in PMA-induced mouse ear edema

O Rickinger1, H Sheriff, R Hirschelmann

  • 1Department of Pharmacy, Martin-Luther-Universität Halle-Wittenberg, Germany.

Agents and Actions
|March 1, 1994
PubMed

Insights

The synthetic opioid peptide DAMEA effectively reduced inflammation in a mouse model. This suggests that inhibiting reactive oxygen species (ROS) may be a key mechanism behind the anti-inflammatory effects of certain analgesics.

Area of Science:

  • Pharmacology
  • Immunology
  • Inflammation Research

Background:

  • The synthetic opioid peptide (D-Ala2) methionine enkephalinamide (DAMEA) is a potent inhibitor of polymorphonuclear neutrophil (PMN) respiratory burst.
  • Reactive oxygen species (ROS) play a significant role in the pathogenesis of inflammatory reactions.

Purpose of the Study:

  • To investigate the anti-inflammatory activity of DAMEA in a mouse model of inflammation.
  • To explore the potential role of ROS inhibition in DAMEA's anti-inflammatory effects.

Main Methods:

  • DAMEA's efficacy was tested in a phorbol 12-myristate 13-acetate (PMA)-induced mouse ear edema model.
  • Dose-dependent inhibition of edema by DAMEA was evaluated.

Main Results:

  • DAMEA demonstrated a dose-dependent inhibition of PMA-induced mouse ear edema.
  • The inhibitory effect was observed within the concentration range of 10(-6) to 10(-9) mol/ear.

Conclusions:

  • DAMEA exhibits significant anti-inflammatory properties in the studied model.
  • Inhibition of ROS production may contribute to the anti-inflammatory activity of DAMEA and potentially other narcotic analgesics.

Related Concept Videos